ARHGEF11 and neoplasm: Of note, 65% (13/20) of 153LMT cells and 44% (8/18) of 153PT cells contained both the Arhgef11 mutation and the Plekha5 mutation, highlighting the power of single-cell technology in predicting possible collaborative actions for tumor evolution and tumor metastasis.